HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Kren, Leos ^a   Valkovsky, Ivo ^b   Dolezel, Jan ^c   Capak, Ivo ^c   Pacik, Dalibor ^a   Poprach, Alexandr ^c   Lakomy, Radek ^c   Redova, Martina ^c,d   Fabian, Pavel ^c   Krenova, Zdenka ^a   Slaby, Ondrej ^c,d  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b UNIVERSITY OF OSTRAVA   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA E ANTIGEN; HLA G ANTIGEN; HLA-E ANTIGEN; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-G ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84861469174     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-58     Document Type: Article

References (29)

1. Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223. 10.1126/science.2326636, 2326636.
2. King A, Allan DS, Bowen M, et al. HLA-E is expressedon trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000, 30:1623-1631. 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M, 10898498.
3. Pradhan D, Kakkar N, Bal A, Singh SK, Joshi K. Sub-typing of renal cell tumours; contribution of ancillary techniques. Diagn Pathol 2009, 4:21. 10.1186/1746-1596-4-21, 2714064, 19558708.
4. Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P. Evaluation of neuroendocrine markers in renal cell carcinoma. Diagn Pathol 2010, 5:28. 10.1186/1746-1596-5-28, 2876076, 20462442.
5. Eckel-Passow JE, Lohse CM, Sheinin Y, Crispen PL, Krco CJ, Kwon ED. Tissue microarrays: one size does not fit all. Diagn Pathol 2010, 5:48. 10.1186/1746-1596-5-48, 2910003, 20609235.
6. Carosella ED, Moreau P, Le Maoult J, et al. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003, 81:199-252.
7. Coupel S, Moreau A, Hamidou M, et al. Expression and repase of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007, 109:2806-2814.
8. Ulbrecht M, Honka T, Person S, Johnson JP, Weiss EH. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol 1992, 149:2945-2953.
9. Ibrahim EC, Guerra N, Lacombe MJ, Angevin E, Chouaib S, Carosella ED, Caignard A, Paul P. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res 2001, 61:6838-6845.
10. Li BL, Lin A, Zhang XJ, Zhang X, Zhang JG, Wang Q, Zhou WJ, Chen HX, Wang TJ, Yan WH. Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens 2009, 74:213-221. 10.1111/j.1399-0039.2009.01302.x, 19531101.
11. Bukur J, Rebmann V, Grosse-Wilde H, Luboldt H, Ruebben H, Drexler I, Sutter G, Huber C, Seliger B. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res 2003, 63:4107-4111.
12. Dunker K, Schlaf G, Bukur J, Altermann WW, Handke D, Seliger B. Expression and regulation of non-classical HLA-G in renal cell carcinoma. Tissue Antigens 2008, 72:137-148. 10.1111/j.1399-0039.2008.01090.x, 18721274.
13. Bossard C, Bézieau S, Matysiak-Budnik T, Volteau C, Laboisse CL, Jotereau F, Mosnier JF. HLA-E/β2 microglobulin over-expression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression. Int J Cancer 2011, [Epub ahead of print].
14. de Kruijf EM, Sajet A, van Nes JG, Natanov R, Putter H, Smit VT, Liefers GJ, van den Elsen PJ, van de Velde CJ, Kuppen PJ. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol 2010, 185:7452-7459. 10.4049/jimmunol.1002629, 21057081.
15. Levy EM, Bianchini M, Von Euw EM, Barrio MM, Bravo AI, Furman D, Domenichini E, Macagno C, Pinsky V, Zucchini C, Valvassori L, Mordoh J. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer. Int J Oncol 2008, 32:633-641.
16. Gooden M, Lampen M, Jordanova ES, Leffers N, Trimbos JB, Gooden M, Lampen M, Jordanova ES, Leffers N, Trimbos JB, van der Burg SH, Nijman H, van Hall T. HLA-E expression by gynecological cancers restrains tumor infiltrating CD8+ T lymphocytes. Proc Natl Acad Sci U S A 2011, 108:10656-10661. 10.1073/pnas.1100354108, 3127933, 21670276.
17. Benevolo M, Mottolese M, Tremante E, Rollo F, Diodoro MG, Ercolani C, Sperduti I, Lo Monaco E, Cosimelli M, Giacomini P. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J Transl Med 2011, 9:184. 10.1186/1479-5876-9-184, 3219584, 22032294.
18. John T, Black MA, Toro TT, Leader D, Gedye CA, Davis ID, Guilford PJ, Cebon JS. Predicting clinical outcome through molecular profiling in stage III melanoma. Clin Cancer Res 2008, 14:5173-5180. 10.1158/1078-0432.CCR-07-4170, 18698035.
19. Mandruzzato S, Callegaro A, Turcatel G, Francescato S, Montesco MC, Chiarion-Sileni V, Mocellin S, Rossi CR, Bicciato S, Wang E, Marincola FM, Zanovello P. A gene expression signature associated with survival in metastatic melanoma. J Transl Med 2006, 4:50. 10.1186/1479-5876-4-50, 1697826, 17129373.
20. Braud VM, Allan DSJ, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795-799. 10.1038/35869, 9486650.
21. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC. NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 2003, 24:136-143. 10.1016/S1471-4906(03)00031-0, 12615209.
22. Michaëlsson J, Teixeira de Matos C, Achour A, Lanier LL, Kärre K, Söderström K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med 2002, 196:1403-1414. 10.1084/jem.20020797, 2194258, 12461076.
23. Gustafson KS, Ginder GD. Interferon-gamma induction of the human leukocyte antigen-E gene is mediated through binding of a complex containing STAT1alpha to a distinct interferon-gamma-responsive element. J Biol Chem 1996, 271:20035-20046. 10.1074/jbc.271.33.20035, 8702722.
24. Malmberg KJ, Levitsky V, Norell H, de Matos CT, Carlsten M, Schedvins K, Rabbani H, Moretta A, Söderström K, Levitskaya J, Kiessling R. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J Clin Invest 2002, 110:1515-1523. 151808, 12438449.
25. Derré L, Corvaisier M, Charreau B, Moreau A, Godefroy E, Moreau-Aubry A, Jotereau F, Gervois N. Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol 2006, 177:3100-3107.
26. Nguyen S, Beziat V, Dhedin N, Kuentz M, Vernant JP, Debre P, Vieillard V. HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT. Bone Marrow Transplant 2009, 43:693-699. 10.1038/bmt.2008.380, 19011664.
27. Zhang C, Zhang J, Sun R, Feng J, Wei H, Tian Z. Opposing effect of IFNgamma and IFNalpha om expression of NKG2 receptors: negative regulation od IFNgamma on NK cells. Int Immunopharmacol 2005, 5:1057-1067. 10.1016/j.intimp.2005.02.003, 15829421.
28. Ravindranath MH, Taniguchi M, Chen CW, Ozawa M, Kaneku H, El-Awar N, Cai J, Terasaki PI. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol Immunol 2010, 47:1121-31. 10.1016/j.molimm.2009.10.024, 19944464.
29. Ravindranath MH, Pham T, El-Awar N, Kaneku H, Terasaki PI. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies. Mol Immunol 2011, 48:423-30. 10.1016/j.molimm.2010.09.011, 21145594.